Speciality: Obstetrics & Gynaecology (OB-GYN)
Description:
Welcome to our podcast. Today, we’re exploring Silent Feto-Maternal Haemorrhage, or FMH. This condition occurs when fetal blood cells cross into the mother’s bloodstream, often without obvious symptoms. Unlike dramatic events such as trauma, silent FMH can happen gradually and go unnoticed. It can lead to fetal anaemia and, in severe cases, even stillbirth if not detected. Diagnosis relies on blood tests like the Kleihauer-Betke test, which helps estimate the amount of fetal blood in the mother’s circulation. Awareness is crucial, especially if there are signs like decreased fetal movements. Early recognition and treatment, such as intrauterine transfusion, can significantly improve outcomes for both mother and baby.
See More Webinars @ Hidoc Webinars
1.
Pirtobrutinib Delays Progression in CLL Already Treated With a BTK Inhibitor
2.
The First Gene Therapy Provides a Durable Response for Non-Muscle-Invasive Bladder Cancer.
3.
We Can Advance Our Patients' Healing by One Step With 1,000 Paper Cranes.
4.
Does Telenursing Improve QOL in Breast Cancer?
5.
Loneliness and social isolation linked to heightened risk of death in those with cancer
1.
Living Better With Advanced Cancer Through Supportive Care
2.
Case Study: Revolutionizing PNH Treatment with Eculizumab for Superior Patient Outcomes
3.
Coagulation Factor Consumption During Severe Inflammation: Mechanisms, Clinical Implications, and Advances
4.
Simulation for Hematology Emergencies: Enhancing Clinical Preparedness and Patient Outcomes
5.
Exploring Digital Cognitive Stimulation for Elderly Breast Cancer Patients
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
2.
Understanding the Importance of Early Cancer Detection
3.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV
4.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
5.
Clinical Insights in Hematology
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation